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Abstract
Background  and  objectives:  There  are  many  studies  conducted  on  reducing  the  frequency  and
severity of  fentayl-induced  cough  during  anesthesia  induction.  We  propose  that  pheniramine
maleate, an  antihistaminic,  may  suppress  this  cough.  We  aim  to  observe  the  effect  of  pheni-
ramine on  fentanyl-induced  cough  during  anesthesia  induction.
Methods:  This  is  a  double-blinded,  prospective,  three-arm  parallel,  randomized  clinical  trial
of 120  patients  with  ASA  (American  Society  of  Anesthesiologists)  physical  status  III  and  IV  who
aged ≥18  and  scheduled  for  elective  open  heart  surgery  during  general  anesthesia.  Patients
were randomly  assigned  to  three  groups  of  40  patients,  using  computer-generated  random
numbers: placebo  group,  pheniramine  group,  and  lidocaine  group.
Results:  Cough  incidence  differed  signiﬁcantly  between  groups.  In  the  placebo  group,  37.5%  of
patients had  cough,  whereas  the  frequency  was  signiﬁcantly  decreased  in  pheniramine  group
(5%) and  lidocaine  group  (15%)  (Fischer  exact  test,  p  =  0.0007  and  p  =  0.0188,  respectively).
There was  no  signiﬁcant  change  in  cough  incidence  between  pheniramine  group  (5%)  and  lido-
caine group  (15%)  (Fischer  exact  test,  p  =  0.4325).  Cough  severity  did  also  change  between
groups. Post  Hoc  tests  with  Bonferroni  showed  that  mean  cough  severity  in  placebo  differed
signiﬁcantly  than  that  of  pheniramine  group  and  lidocaine  group  (p  <  0.0001  and  p  =  0.009,
respectively).  There  was  no  signiﬁcant  change  in  cough  severity  between  pheniramine  group
and lidocaine  group  (p  =  0.856).
Conclusion:  Intravenous  pheniramine  is  as  effective  as  lidocaine  in  preventing  fentayl-induced
cough. Our  results  emphasize  that  pheniramine  is  a  convenient  drug  to  decrease  this  cough.ira  de  Anestesiologia.  Published  by  Elsevier  Editora  Ltda.  This
 under  the  CC  BY-NC-ND  license  (http://creativecommons.org/© 2015  Sociedade  Brasile
is an  open  access  article
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Efeito  de  feniramina  sobre  a  tosse  induzida  por  fentanil:  estudo  clínico,  randômico,
duplo-cego  e  controlado  com  placebo
Resumo
Justiﬁcativa  e  objetivos:  Há  muitos  estudos  sobre  a  reduc¸ão  da  frequência  e  gravidade  da  tosse
induzida por  fentanil  durante  a  induc¸ão  da  anestesia.  Propomos  que  maleato  de  feniramina,  um
anti-histamínico,  pode  suprimir  essa  tosse.  Nosso  objetivo  foi  observar  o  efeito  de  feniramina
sobre a  tosse  induzida  por  fentanil  durante  a  induc¸ão  da  anestesia.
Métodos:  Este  é  um  estudo  clínico  prospectivo,  de  três  brac¸os  paralelos,  randômico  e  duplo-
cego, de  120  pacientes  com  estado  físico  ASA  III  e  IV  (de  acordo  com  a  Sociedade  Americana  de
Anestesiologistas),  com  idades  ≥  18  anos  e  programados  para  cirurgia  cardíaca  aberta  eletiva
sob anestesia  geral.  Os  pacientes  foram  divididos  aleatoriamente  em  três  grupos  de  40  pacientes
cada, usando  números  aleatórios  gerados  por  computador:  grupo  placebo,  grupo  feniramina  e
grupo lidocaína.
Resultados:  A  incidência  de  tosse  diferiu  signiﬁcativamente  entre  os  grupos.  No  grupo  placebo,
37,5% dos  pacientes  apresentaram  tosse,  enquanto  que  a  frequência  foi  signiﬁcativamente
reduzida  no  grupo  feniramina  (5%)  e  no  grupo  lidocaína  (15%)  (teste  exato  de  Fischer,  p  =  0,0007
e p  =  0,0188,  respectivamente).  Não  houve  alterac¸ão  signiﬁcativa  na  incidência  de  tosse  entre
os grupos  feniramina  (5%)  e  lidocaína  (15%)  (teste  exato  de  Fischer,  p  =  0,4325).  A  gravidade  da
tosse também  alterou  entre  os  grupos.  Testes  post  hoc  com  Bonferroni  mostraramu  que  a  média
da gravidade  da  tosse  no  grupo  placebo  diferiu  signiﬁcativamente  das  médias  dos  grupos  feni-
ramina e  lidocaína  (p  <  0,0001  e  p  =  0,009,  respectivamente).  Não  houve  alterac¸ão  signiﬁcativa
na gravidade  da  tosse  entre  o  grupo  feniramina  e  grupo  lidocaína  (p  =  0,856).
Conclusão:  Feniramina  por  via  intravenosa  possui  a  mesma  eﬁcácia  que  lidocaína  na  prevenc¸ão
da tosse  induzida  por  fentanil.  Os  resultados  enfatizam  que  feniramina  é  um  medicamento
conveniente  para  diminuir  essa  tosse.
© 2015  Sociedade  Brasileira  de  Anestesiologia.  Publicado  por  Elsevier  Editora  Ltda.  Este
é um  artigo  Open  Access  sob  a  licença  de  CC  BY-NC-ND  (http://creativecommons.org/
licenses/by-nc-nd/4.0/).
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Introduction
ntravenous  fentanyl  which  is  used  mainly  for  induc-
ion  of  anesthesia  frequently  causes  an  irritating  cough
n  the  patient.1 The  prevalence  of  fentanyl-induced
ough  ranges  from  21.6%  to  74%.2--5 It  is  generally  tran-
itory  and  limited,  but  it  can  be  harmful  in  cases
ith  increased  intracranial,  intraocular  or  intra-abdominal
ressure;  cerebral  aneurysm,  brain  trauma  and  hernia,  dis-
ecting  aortic  aneurysm,  pneumothorax  or  reactive  airway
isease.4--7 Although  the  mechanism  of  fentanyl-induced
ough  has  not  been  fully  clariﬁed,  it  is  thought  that
llergic  mediators  such  as  histamine  may  cause  it.8 Var-
ous  medicaments  and  methods  have  been  used  with
arying  degrees  of  success  to  hinder  or  relieve  this  side-
ffect.2 One  study  reported  that  lidocaine  2  mg/kg  iv
iven  one  minute  before  fentanyl  decreased  the  preva-
ence  of  cough  from  65%  (according  to  the  control  group)
o  14%.6 Another  study  reported  that  iv  fentanyl  admin-
stered  in  diluted  form  or  more  slowly  markedly  hindered
ough.9
Many  solutions  have  been  proposed  for  this  cough  of
nidentiﬁed  origin.  We  wanted  to  investigate  the  effect
f  pheniramine  on  fentanyl-induced  cough.  The  purpose  of
his  study  was  to  compare  the  effect  of  the  antihistaminic
heniramine  maleate  and  lidocaine  on  fentanyl-induced
ough.
C
n
r
wethod
esign
his  is  a double-blinded,  prospective,  three-arm  parallel,
andomized  clinical  trial  conducted  in  a  research  hospital
etween  September  2013  and  April  2014.  The  approval  of
he  Ethics  Committee  of  our  hospital  and  informed  consent
orms  were  taken  from  all  patients  participating  in  the  study
Decision  n◦ 2013/13).  One  hundred  and  twenty  ASA  (Amer-
can  Society  of  Anesthesiologists)  physical  status  III  and  IV
atients  aged  ≥18  and  scheduled  for  elective  open  heart
urgery  during  general  anesthesia,  were  randomly  assigned
o  one  of  three  groups  of  40  patients  each,  using  computer-
enerated  random  numbers:  placebo  group,  pheniramine
roup,  and  lidocaine  group.  Dr.  ZA  was  responsible  for  drug
reparation  and  the  allocation  sequences  (contained  in  a
et  of  sealed  envelopes).  The  observers  and  all  the  patients
nvolved  in  the  study  were  blinded.
nclusion  criteria
onsecutive  patients  planned  for  open  heart  surgery  (coro-
ary  artery  by-pass,  mitral  and  aortic  valve  replacement),
eceiving  no  premedication,  and  in  the  ASA-III  and  IV  class
ere  included.
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Table  1  Patient  characteristics  in  three  groups.
Feature  Placebo  group  (n  =  40)  Pheniramine  group  (n  =  40)  Lidocaine  group  (n  =  40)  p
Age  (yr)  55.98  ±  11.5  61.25  ±  11.84  56.48  ±  12.22  0.094
Male (%)  75  80  60  0.118
Weight (kg)  74.03  ±  12.29  74.02  ±  12.83  74.13  ±  12.27  0.999
Smokers (%)  48.6  33.3  32.4  0.289
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IEx-smokers  (%)  21.7  14.3  
Exclusion  criteria
Those  who  had  premedication,  pharyngitis  in  the  last
<3  weeks,  chronic  obstructive  pulmonary  disease,  chronic
cough,  drug  allergy,  history  of  asthma,  treatment  with  bron-
chodilators  or  steroids  for  the  last  one  month,  and  who  were
in  the  class  ASA-V  were  excluded.
Sample  size
Our  power  analysis  showed  that  using  a  sample  size  of  40
patients  per  group  achieves  82%  power  to  detect  an  effect
size  (W)  of  0.5  using  2  degrees  of  freedom  Chi-Square  Test
with  a  signiﬁcance  level  (alpha)  of  0.05.
Interventions
After  the  patients  entered  the  operation  room,  vascular
access  was  established  by  placing  a  22-G  cannula  in  one  of
the  veins  in  the  forearm,  and  infusion  with  saline  3  mL/kg
was  started.  As  noninvasive  monitoring,  electrocardiogra-
phy  (ECG),  blood  pressure  (BP),  and  pulse  oxygen  saturation
(SpO2)  were  provided.  Measurements  were  made  in  every
5  min.  If  needed  (SpO2 <  95%),  oxygen  support  (4  L/min)
was  given  via  an  oxygen  face  mask.  One  minute  before
induction  and  fentanyl  administration,  pheniramine  maleate
45.5  mg  iv  bolus  (Avil,  2  mL  ampoule,  Sandoz,  Turkey)  was
administered  to  40  patients  in  the  pheniramine  group,  lido-
caine  (Aritmal  2%,  5  mL,  Osel  drug,  Turkey)  1  mg/kg  to
40  patients  in  the  lidocaine  group  and  saline  5  mL  to  40
patients  in  the  placebo  group,  respectively.  One  minute
after  the  treatment,  fentanyl  5  g/kg  iv  bolus  (Fentanyl
0.05  mg/mL,  10  mL  ampoule,  Johnson&Johnson,  Belgium)
was  given  within  5  s  to  the  patients  in  each  group.  The
patients  were  observed  for  the  side-effects  of  fentanyl,
and  any  side-effect  seen  was  noted  down.  The  sever-
ity  of  cough  was  recorded  as  mild  (1--2),  medium  (3--5),
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Table  2  The  comparison  of  cough  characteristics  in  three  groups
Variables  Placebo  group  (n  =  40)  Pheniram
Cough  severity  (0--3)  0.63  ±  0.93  0.05  ±  0.2
Cough  incidence,  n  (%)  37.5  (15)  5  (2)  
No cough  62.5  (25)  95  (38)  
Mild 17.5  (7)  5  (2)  
Moderate  15  (6)  0  
Severe 5  (2)  0  
a Oneway ANOVA.10.7  0.544
nd  severe  (>5).  Following,  induction  was  conducted  with
ropofol  2.5  mg/kg  and  rocuronium  0.6  mg/kg.  The  patients
ere  manually  ventilated  for  2.5  min  and  then  orotra-
heal  intubation  was  completed.  The  patients  were  then
echanically  ventilated  with  a 7  mL/kg  tidal  volume  at  a
ate  of  12  breaths  per  minute.  Thereafter,  invasive  arte-
ial  catheterization  of  left  radial  artery  and  central  venous
atheterization  to  the  right  internal  jugular  vein  were  pro-
ided.  The  anesthesia  was  maintained  with  fusion  of  50%
2/air,  5%  desﬂurane,  2--3  g/kg  remifentanyl  and  rocuro-
ium  (0.1  mg/kg/30  min).  After  the  operation  was  over,  the
atients  were  transferred  to  the  Intensive  Care  Unit  of  Car-
iovascular  Surgery  Clinic  as  intubated,  monitored  (invasive
lood  pressure,  SpO2,  and  ECG),  and  manually  ventilated
ith  oxygen  8  L/min.
tatistics
he  frequencies  of  coughing  and  the  proportions  of  sex  and
SA  class  were  compared  using  the  chi-square  test  or  Fisher’s
xact  test.  One-way  ANOVA  analysis  of  variance  was  used
o  compare  the  age  and  weight  among  the  four  groups  and
ost  Hoc  tests  with  Bonferroni  correction  was  used  to  deﬁne
hich  groups  differ.  p  <  0.05  was  considered  as  statistically
igniﬁcant.
esults
here  was  no  statistically  signiﬁcant  difference  between  the
hree  groups  with  regard  to  age,  gender,  weight,  and  smok-
ng  habits  (p  >  0.05  for  all,  Table  1).
Cough  incidence  differed  signiﬁcantly  between  groups.
n  the  placebo  group,  37.5%  of  patients  had  cough,  whereas
he  frequency  was  signiﬁcantly  decreased  in  pheniramine
roup  (5%)  and  lidocaine  group  (15%)  (Fischer  exact  test,
 =  0.0007  and  p  =  0.0188,  respectively;  Table  2).  There
as  no  signiﬁcant  change  in  cough  incidence  between
.
ine  group  (n  =  40)  Lidocaine  group  (n  =  40)  p
2  0.2  ±  0.52  <0.0001a
15  (6)  <0.0001
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heniramine  group  (5%)  and  lidocaine  group  (15%)  (Fischer
xact  test,  p  =  0.4325).
Cough  severity  did  also  change  between  groups.  Post
oc  tests  with  Bonferroni  showed  that  mean  cough  severity
n  placebo  differed  signiﬁcantly  than  that  of  pheniramine
roup  and  lidocaine  group  (p  <  0.0001  and  p  =  0.009,  respec-
ively).  There  was  no  signiﬁcant  change  in  cough  severity
etween  pheniramine  group  and  lidocaine  group  (p  =  0.856).
iscussion
e  saw  that  administration  of  fentanyl  iv  bolus  caused  cough
n  37.5%  of  the  patients.  We  also  found  that  fentanyl-induced
ough  could  be  inhibited  by  pheniramine  and  lidocaine.  The
ost  important  ﬁnding  of  this  study  was  that  pheniramine
aleate,  an  antihistaminic,  reduced  fentanyl-induced  cough
ore  than  lidocaine  used  for  this  purpose.
The  fentanyl-induced  cough  reﬂex  occurs  frequently
ollowing  anesthetic  induction.  Lui  et  al.10 administered  fen-
anyl  at  the  dose  we  used  (5  g/kg)  via  peripheral  venous
oute  and  observed  cough  in  43%  of  the  patients.  Yeh
t  al.4 observed  fentanyl-induced  cough  due  to  injection
f  fentanyl  1.5  g/kg  in  21.6%  of  their  patients.  Lin  et  al.7
dministered  fentanyl  2.5  g/kg  within  2  s  and  found  a  high
ough  rate  of  65%.  A  double-blind  study  reported  that  with  a
igher  dose  of  fentanyl  (4  g/kg),  cough  was  seen  in  74.4%  of
he  patients.5 The  differences  in  the  prevalence  of  cough  in
hese  studies  may  depend  upon  the  injection  site  and  route
f  fentanyl,  speed  of  injection,  and  dose  and  concentration
f  the  drug.  Also  genetic  factors  and  co-morbidities  may  play
 role.
Particularly  in  open  cardiac  operations,  to  maintain
table  hemodynamic  parameters  by  inhibiting  the  stress
esponse  of  hemodynamics  to  very  painful  sternotomy,  high-
ose  narcotic  analgesics  are  used  in  the  induction  and
aintenance  of  anesthesia.11 For  this  purpose,  fentanyl
because  it  provides  rapid  onset,  short  duration,  intense
nalgesia,  reduced  cardiovascular  depression,  and  low  his-
amine  release)  is  one  of  the  most  frequently  used  opioid
nalgesics.12,13 For  the  same  purpose,  we  also  administered
entanyl  in  doses  higher  than  routinely  used.  We  think  that
he  relatively  lower  incidence  of  cough  found  in  our  study
an  be  due  to  two  reasons.  First,  we  administered  fentanyl
ithin  5  s  that  is  a  longer  period  discussed  to  other  studies.
econd,  our  patients  were  relatively  older  than  the  patients
f  previous  studies.5,7 As  the  patients  get  older,  cough  reﬂex
s  diminished  due  to  lower  irritating  receptor  activity.7 In
 study  on  children  aged  4--10  years,  a  bolus  of  fentanyl
 g/kg  via  peripheral  venous  route  caused  cough  reﬂex  in
3.5%  of  the  children.14 In  Lin  et  al.’s  study,7 the  average
ge  of  the  controls  was  36.8  years.
There  are  various  theories  on  fentanyl-induced  cough.
entanyl  inhibits  central  sympathetic  outﬂow,  causes  vagal
redominance,  and  leads  to  cough  and  bronchoconstric-
ion,  and  bronchospasm.4--6,15 Opioids  may  induce  cough
hrough  various  mechanisms  including  through  a  pulmonary
hemoreﬂex,  direct  stimulation  of  the  vagal  nucleus,  the
elease  of  neuropeptides  after  activation  of  -opioid  recep-
ors  and  stimulation  of  the  irritant  receptors  in  upper
ulmonary  mucosa.16--19 Yeh  et  al.4 reported  that  fentanyl
an  cause  cough  by  stimulating  the  irritant  receptors  inZ.  Arslan  et  al.
racheal  smooth  muscle.  Opioids  release  histamine  from
ast  cells  to  a  variable  degree,  with  codeine,  morphine
nd  meperidine  having  the  greatest  histamine-releasing
apacity,  while  tramadol,  fentanyl  and  remifentanyl  do  not
elease  histamine  and  are  recommended  in  pulmonary  dis-
ase  requiring  opioid  administration.20 On  the  other  hand,
amei  et  al.8 in  their  study  on  mice  reported  that  fentanyl
auses  cough  by  increasing  the  quantity  of  citric  acid  which
nduces  cough  and  by  signiﬁcantly  increasing  the  concentra-
ion  of  histamine  in  bronchoalveolar  lavage  ﬂuid.
To  inhibit  the  cough  reﬂex,  various  medicaments  are
sed  (ephedrine,  beclomethasone,  B2-receptor  agonist,
etamine,  clonidine,  propofol).  All  these  medications  have
ronchorelaxant  effect  on  the  airway  smooth  muscle.4,5,7,21
idocaine,  one  of  the  most  frequently  used  medicaments,
as  been  shown  to  reduce  airway  reactiveness,  possibly
ia  mechanically  and  chemically  induced  airway  reﬂexes.15
andey  et  al.6 in  their  double-blind  study  reported  that  lido-
aine  administered  one  minute  before  fentanyl  could  inhibit
entanyl-induced  cough.
As  known,  histamine  shows  its  effects  on  target  tis-
ues  such  as  airway  smooth  muscle,  bronchial  epithelium,
ecretary  glands,  mast  cells  and  epithelial  cells  through
rominently  H1,  as  well  as  H2  and  H4  receptors.  Pheni-
amine,  an  H1-receptor  antagonist,  affects  by  competing
ith  histamine  on  H1-receptors.  H1-receptor  antagonists,
n  addition  to  their  anti-allergic  blockade  on  the  H1-
eceptors,  prevent  the  release  of  inﬂammatory  mediators
rom  basophils  and  mast  cells.  They  also  inhibit  the
igration  of  eosinophils,  basophils  and/or  neutrophils.22,23
herefore  we  thought  that  pheniramine  may  be  more  effec-
ive  than  lidocaine  to  alleviate  the  fentanyl-induced  cough.
In  our  study,  we  also  showed  that  lidocaine  had  an
mportant  effect  on  the  frequency  and  severity  of  fentanyl-
nduced  cough.  Additionally,  we  found  that  pre-treatment
ith  iv  45.5  mg  pheniramine  maleate  suppressed  the
entanyl-induced  cough  during  general  anesthesia  induction,
ut  more  clinical  trials  are  needed  to  evaluate  its  effect.  In
ur  anesthesia  clinic,  the  use  of  pheniramine  is  not  routine.
ecause  another  indication  of  pheniramine  is  its  anti-allergic
ffects  due  to  blood  products  in  patients  underwent  to  open
ardiac  surgery,  we  included  only  these  patients  in  our  study.
onclusion
ntravenous  pheniramine  is  as  effective  as  lidocaine  in  pre-
enting  fentayl-induced  cough.  Our  results  emphasize  that
heniramine  is  a  convenient  drug  to  decrease  this  cough.
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